Clinical Trial
Phase I trial of high-dose methotrexate with modified citrovorum factor rescue
- PMID: 348306
Item in Clipboard
Clinical Trial
Phase I trial of high-dose methotrexate with modified citrovorum factor rescue
Cancer Treat Rep.
1978 Mar.
No abstract available
Similar articles
-
High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.Cancer Treat Rep. 1977 Aug;61(5):779-83. Cancer Treat Rep. 1977. PMID: 302143 Clinical Trial. No abstract available.
-
Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.Cancer Treat Rep. 1978 Sep;62(9):1295-304. Cancer Treat Rep. 1978. PMID: 356984 Clinical Trial.
-
Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.Cancer Treat Rep. 1976 May;60(5):527-33. Cancer Treat Rep. 1976. PMID: 1086714 Clinical Trial.
-
High-dose methotrexate with folinic acid rescue.Am J Hosp Pharm. 1977 Sep;34(9):961-5. Am J Hosp Pharm. 1977. PMID: 333910 Review.
-
Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.Ther Drug Monit. 1980;2(2):177-85. Ther Drug Monit. 1980. PMID: 6762711 Review.
Cited by
-
Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy.Cancer Chemother Pharmacol. 1991;28(3):199-204. doi: 10.1007/BF00685509. Cancer Chemother Pharmacol. 1991. PMID: 1649705
-
The practical benefits of pharmacokinetics in the use of antineoplastic agents.Cancer Chemother Pharmacol. 1980;4(3):139-45. doi: 10.1007/BF00254011. Cancer Chemother Pharmacol. 1980. PMID: 6994913 Review. No abstract available.